ロード中...
Randomized Phase III Trial of ABVD Versus Stanford V With or Without Radiation Therapy in Locally Extensive and Advanced-Stage Hodgkin Lymphoma: An Intergroup Study Coordinated by the Eastern Cooperative Oncology Group (E2496)
PURPOSE: Although ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) has been established as the standard of care in patients with advanced Hodgkin lymphoma, newer regimens have been investigated, which have appeared superior in early phase II studies. Our aim was to determine if failure-fr...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society of Clinical Oncology
2013
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3574266/ https://ncbi.nlm.nih.gov/pubmed/23182987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.43.4803 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|